BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P100
Near historical high
vs 2Y Ago
17.8x
Strong expansion
Streak
3 yr
Consecutive growthAccelerating
PeriodValue
2025734.14%
202445.32%
202341.22%
2022-13.85%
2021-3.60%
2020-53.17%
20193.22%
2018-124.98%
201723.01%
2016-307.43%